[{"Assets_0_Q2_USD":1751751000.0,"CommonStockSharesOutstanding_0_Q2_shares":157096873.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-965000.0,"NetIncomeLoss_1_Q2_USD":-41990000.0,"NetIncomeLoss_2_Q2_USD":-138388000.0,"StockholdersEquity_0_Q2_USD":1091168000.0,"Ticker":"ALKS","CIK":"1520262","name":"ALKERMES PLC.","OfficialName":"Alkermes plc Ordinary Shares","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4612884468.0","Country":"Ireland","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190725"}]